185 related articles for article (PubMed ID: 11370554)
1. Radiotherapy of the neuroaxis for palliative treatment of leptomeningeal carcinomatosis.
Hermann B; Hültenschmidt B; Sautter-Bihl ML
Strahlenther Onkol; 2001 Apr; 177(4):195-9. PubMed ID: 11370554
[TBL] [Abstract][Full Text] [Related]
2. Craniospinal irradiation(CSI) in patients with leptomeningeal metastases: risk-benefit-profile and development of a prognostic score for decision making in the palliative setting.
Devecka M; Duma MN; Wilkens JJ; Kampfer S; Borm KJ; Münch S; Straube C; Combs SE
BMC Cancer; 2020 Jun; 20(1):501. PubMed ID: 32487151
[TBL] [Abstract][Full Text] [Related]
3. Concurrent radiotherapy and intrathecal methotrexate for treating leptomeningeal metastasis from solid tumors with adverse prognostic factors: A prospective and single-arm study.
Pan Z; Yang G; He H; Zhao G; Yuan T; Li Y; Shi W; Gao P; Dong L; Li Y
Int J Cancer; 2016 Oct; 139(8):1864-72. PubMed ID: 27243238
[TBL] [Abstract][Full Text] [Related]
4. Combined-modality treatment of leptomeningeal gliomatosis.
Chamberlain MC
Neurosurgery; 2003 Feb; 52(2):324-29; discussion 330. PubMed ID: 12535360
[TBL] [Abstract][Full Text] [Related]
5. Intrathecal trastuzumab (Herceptin) and methotrexate for meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer: a case report.
Stemmler HJ; Mengele K; Schmitt M; Harbeck N; Laessig D; Herrmann KA; Schaffer P; Heinemann V
Anticancer Drugs; 2008 Sep; 19(8):832-6. PubMed ID: 18690096
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes of breast leptomeningeal disease treated with intrathecal trastuzumab, intrathecal chemotherapy, or whole brain radiation therapy.
Figura NB; Rizk VT; Mohammadi H; Evernden B; Mokhtari S; Yu HM; Robinson TJ; Etame AB; Tran ND; Liu J; Washington I; Diaz R; Czerniecki BJ; Soliman H; Han HS; Sahebjam S; Forsyth PA; Ahmed KA
Breast Cancer Res Treat; 2019 Jun; 175(3):781-788. PubMed ID: 30859348
[TBL] [Abstract][Full Text] [Related]
7. Correlation of MRI and clinical features in meningeal carcinomatosis.
Watanabe M; Tanaka R; Takeda N
Neuroradiology; 1993; 35(7):512-5. PubMed ID: 8232877
[TBL] [Abstract][Full Text] [Related]
8. Outcome and prognostic factors following palliative craniospinal irradiation for leptomeningeal carcinomatosis.
El Shafie RA; Böhm K; Weber D; Lang K; Schlaich F; Adeberg S; Paul A; Haefner MF; Katayama S; Sterzing F; Hörner-Rieber J; Löw S; Herfarth K; Debus J; Rieken S; Bernhardt D
Cancer Manag Res; 2019; 11():789-801. PubMed ID: 30697071
[TBL] [Abstract][Full Text] [Related]
9. Meningeal carcinomatosis from an ovarian primary with complete response to adjuvant chemotherapy after cranial irradiation.
Ohta H; Koyama R; Nagai T; Hirayama Y; Saito S; Yonesaka A
Int J Clin Oncol; 2001 Jun; 6(3):157-62. PubMed ID: 11706787
[TBL] [Abstract][Full Text] [Related]
10. Management of leptomeningeal malignancy.
Pentheroudakis G; Pavlidis N
Expert Opin Pharmacother; 2005 Jun; 6(7):1115-25. PubMed ID: 15957966
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer leptomeningeal metastasis--the role of multimodality treatment.
Rudnicka H; Niwińska A; Murawska M
J Neurooncol; 2007 Aug; 84(1):57-62. PubMed ID: 17310266
[TBL] [Abstract][Full Text] [Related]
12. Radiation therapy for leptomeningeal cancer.
Mehta M; Bradley K
Cancer Treat Res; 2005; 125():147-58. PubMed ID: 16211888
[TBL] [Abstract][Full Text] [Related]
13. Concurrent platinum and docetaxel chemotherapy and external radical radiotherapy in patients with invasive transitional cell bladder carcinoma. A preliminary report of tolerance and local control.
Varveris H; Delakas D; Anezinis P; Haldeopoulos D; Mazonakis M; Damilakis J; Metaxaris G; Chondros N; Mavromanolakis E; Daskalopoulos G; Dimitrakopoulos A; Kranidis A
Anticancer Res; 1997; 17(6D):4771-80. PubMed ID: 9494605
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
[TBL] [Abstract][Full Text] [Related]
15. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
16. Treatment for meningeal carcinomatosis in breast cancer.
Yap HY; Yap BS; Rasmussen S; Levens ME; Hortobagyi GN; Blumenschein GR
Cancer; 1982 Jul; 50(2):219-22. PubMed ID: 6177395
[TBL] [Abstract][Full Text] [Related]
17. Meningeal carcinomatosis in patients with breast carcinoma. Clinical features, prognostic factors, and results of a high-dose intrathecal methotrexate regimen.
Fizazi K; Asselain B; Vincent-Salomon A; Jouve M; Dieras V; Palangie T; Beuzeboc P; Dorval T; Pouillart P
Cancer; 1996 Apr; 77(7):1315-23. PubMed ID: 8608509
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer leptomeningeal metastasis: the results of combined treatment and the comparison of methotrexate and liposomal cytarabine as intra-cerebrospinal fluid chemotherapy.
Niwińska A; Rudnicka H; Murawska M
Clin Breast Cancer; 2015 Feb; 15(1):66-72. PubMed ID: 25287959
[TBL] [Abstract][Full Text] [Related]
19. Isolated leptomeningeal carcinomatosis (carcinomatous meningitis) after taxane-induced major remission in patients with advanced breast cancer.
Kosmas C; Malamos NA; Tsavaris NB; Stamataki M; Gregoriou A; Rokana S; Vartholomeou M; Antonopoulos MJ
Oncology; 2002; 63(1):6-15. PubMed ID: 12187065
[TBL] [Abstract][Full Text] [Related]
20. Leptomeningeal carcinomatosis from squamous cell carcinoma of the supraglottic larynx.
Thompson SR; Veness MJ; Morgan GJ; Shannon J; Kench JG
Australas Radiol; 2003 Sep; 47(3):325-30. PubMed ID: 12890260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
